Dare Bioscience was selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by the Advanced Research Projects Agency for Health. As an Investor Catalyst Hub spoke, Dare gains access to potential funding and flexible contracting for faster award execution compared to traditional government contracts. Spoke membership also offers opportunities to provide input on ARPA-H challenge areas and priorities, along with access to valuable networking opportunities and a robust resource library.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DARE:
- Daré Bioscience Secures Funding and Forges Royalty Agreements
- Xoma acquires economic interest in three assets from Dare Bioscience
- Dare Bioscience secures $22M in non-dilutive strategic royalty financing
- Dare Bioscience announces it will receive payment of $1M under grant agreement
- Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1